Norway vs United States of America: Proportion of the target population who received the final dose of
Norway
91.0%
in 2024
United States of America
52.0%
in 2024
Norway rank
9th
United States of America rank
12th
Proportion of the target population who received the final dose of over time
- Norway
- United States of America
How they compare
Norway currently reports 91.0% against 52.0% in United States of America, a difference of 39.0%.
That makes Norway's figure about 1.8 times United States of America's.
Across all 15 years both countries report, Norway has been ahead every year.
Norway ranks 9th and United States of America ranks 12th of 107 countries.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Norway | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 78.5% | 31.6% | 46.9% | Norway |
| 2020s | 90.6% | 50.8% | 39.8% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Norway or United States of America?
- Norway, at 91.0% against 52.0% in United States of America as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Norway and United States of America?
- 39.0%, with Norway ahead.
- How many years of comparable data are there for Norway and United States of America?
- 15 years are reported by both, from 2010 to 2024.
- How do Norway and United States of America rank globally for proportion of the target population who received the final dose of?
- Norway ranks 9th and United States of America ranks 12th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.